Literature DB >> 26996530

Amelioration of Ischemic Brain Injury in Rats With Human Umbilical Cord Blood Stem Cells: Mechanisms of Action.

Laura L Hocum Stone1, Feng Xiao, Jessica Rotschafer, Zhenhong Nan, Mario Juliano, Cyndy D Sanberg, Paul R Sanberg, Nicole Kuzmin-Nichols, Andrew Grande, Maxim C-J Cheeran, Walter C Low.   

Abstract

Despite the high prevalence and devastating outcome, there remain a few options for treatment of ischemic stroke. Currently available treatments are limited by a short time window for treatment and marginal efficacy when used. We have tested a human umbilical cord blood-derived stem cell line that has been shown to result in a significant reduction in stroke infarct volume as well as improved functional recovery following stroke in the rat. In the present study we address the mechanism of action and compared the therapeutic efficacy of high- versus low-passage nonhematopoietic umbilical cord blood stem cells (nh-UCBSCs). Using the middle cerebral arterial occlusion (MCAo) model of stroke in Sprague-Dawley rats, we administered nh-UCBSC by intravenous (IV) injection 2 days following stroke induction. These human cells were injected into rats without any immune suppression, and no adverse reactions were detected. Both behavioral and histological analyses have shown that the administration of these cells reduces the infarct volume by 50% as well as improves the functional outcome of these rats following stroke for both high- and low-passaged nh-UCBSCs. Flow cytometry analysis of immune cells present in the brains of normal rats, rats with ischemic brain injury, and ischemic animals with nh-UCBSC treatment confirmed infiltration of macrophages and T cells consequent to ischemia and reduction to normal levels with nh-UCBSC treatment. Flow cytometry also revealed a restoration of normal levels of microglia in the brain following treatment. These data suggest that nh-UCBSCs may act by inhibiting immune cell migration into the brain from the periphery and possibly by inhibition of immune cell activation within the brain. nh-UCBSCs exhibit great potential for treatment of stroke, including the fact that they are associated with an increased therapeutic time window, no known ill-effects, and that they can be expanded to high numbers for, and stored for, treatment.

Entities:  

Mesh:

Year:  2016        PMID: 26996530     DOI: 10.3727/096368916X691277

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  15 in total

Review 1.  Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?

Authors:  Nikunj Satani; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 2.  From cord to caudate: characterizing umbilical cord blood stem cells and their paracrine interactions with the injured brain.

Authors:  Priya F Maillacheruvu; Lauren M Engel; Isaiah T Crum; Devendra K Agrawal; Eric S Peeples
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

Review 3.  Ischemic Brain Stroke and Mesenchymal Stem Cells: An Overview of Molecular Mechanisms and Therapeutic Potential.

Authors:  Yang Jingli; Wang Jing; Yasmeen Saeed
Journal:  Stem Cells Int       Date:  2022-05-25       Impact factor: 5.131

Review 4.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

5.  The Effect of Exosomes Derived from Bone Marrow Stem Cells in Combination with Rosuvastatin on Functional Recovery and Neuroprotection in Rats After Ischemic Stroke.

Authors:  Mohsen Safakheil; Hosein Safakheil
Journal:  J Mol Neurosci       Date:  2020-01-23       Impact factor: 3.444

Review 6.  Cellular therapy for traumatic neurological injury.

Authors:  Charles S Cox
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

Review 7.  Efficacy of stem cell-based therapies for stroke.

Authors:  Matthew R Chrostek; Emily G Fellows; Andrew T Crane; Andrew W Grande; Walter C Low
Journal:  Brain Res       Date:  2019-08-02       Impact factor: 3.252

8.  Harnessing the anti-inflammatory properties of stem cells for transplant therapy in hemorrhagic stroke.

Authors:  Sydney Corey; Brooke Bonsack; Matt Heyck; Alex Shear; Nadia Sadanandan; Henry Zhang; Cesar V Borlongan
Journal:  Brain Hemorrhages       Date:  2020-01-22

Review 9.  Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.

Authors:  Qingxue Xu; Bo Zhao; Yingze Ye; Yina Li; Yonggang Zhang; Xiaoxing Xiong; Lijuan Gu
Journal:  J Neuroinflammation       Date:  2021-05-31       Impact factor: 8.322

10.  Human Umbilical Cord Mesenchymal Stem Cells Preserve Adult Newborn Neurons and Reduce Neurological Injury after Cerebral Ischemia by Reducing the Number of Hypertrophic Microglia/Macrophages.

Authors:  Willie Lin; Yogi Chang-Yo Hsuan; Mao-Tsun Lin; Ting-Wei Kuo; Cheng-Hsien Lin; Yu-Chin Su; Ko-Chi Niu; Ching-Ping Chang; Hung-Jung Lin
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.